Now I'll write the consolidated review.

## Summary

This paper proposes a conformalized procedure for constructing lower prediction bounds (LPBs) for counterfactual survival times under different treatments in general right-censored data. The core idea is to transform the coverage probability into a reweighted expectation via a density ratio ω(x) = 1/γ(x) = 1/p(W=w, e=1|X), then apply weighted conformal prediction (Lei & Candès, 2021) to calibrate the LPB using only uncensored observations from the treated group. The paper provides Theorem 4.1 (a distribution-free bound with an error term depending on weight estimation quality) and Theorem 4.2 (doubly robust asymptotic guarantee), and validates the method on synthetic data and a real lung cancer clinical dataset with 541 patients.

## Strengths

- **Extension to general right-censored data with counterfactual LPBs**: The paper addresses a real gap — prior exact-guarantee conformal survival methods (Candès et al., 2023; Gui et al., 2024) are restricted to Type-I censoring where the censoring time C_i is known, while Davidov et al. (2025) handles general right-censored data but only gives PAC-type guarantees. The proposed method targets general right-censored data with a distribution-free bound (Theorem 4.1, Eq. 4), which is a meaningful step forward.

- **Doubly robust property**: Theorem 4.2 shows that asymptotic coverage remains valid if either the weight function γ̂(x) or the counterfactual quantile estimator is consistently estimated. This is a genuinely useful theoretical contribution; the fact that the method compensates for misspecification of one component is practically valuable.

- **Demonstrated robustness to outliers**: Figure 3 shows that when 10% of survival times are replaced with extreme negative values (N(1,2), N(10,2), N(20,2)), the proposed method maintains coverage near 90% while the "Focus" and "Fused" baselines drop substantially. This is a clear empirical advantage over prior PAC-type methods.

- **Clinically grounded real-data evaluation**: The real lung cancer dataset (541 patients) covers four radiochemotherapy regimens (VMAT, IMRT, concurrent/induction/consolidation chemotherapy). The LPB analysis differentiates between regimens in patterns consistent with prior clinical knowledge, and the covariate adaptiveness analysis (Figure 5) shows meaningful variation with known prognostic factors (stage, KPS, tumor volume).

## Weaknesses

### Major

- **Unjustified critical step in the derivation of the coverage bound (Equation 1, steps (ii)–(iii))**: The core theoretical justification for reducing the counterfactual coverage problem to a weighted conformal prediction problem hinges on Equation (1). Step (ii) multiplies P(T ≤ A | X, W=w) by 1/p(e=1|X, W=w) with the annotation "comes from the tower property" — the tower property alone does not justify inserting this factor. Step (iii) claims an inequality (≤) that goes from P(T ≤ A | X, W=w) × 1/p(e=1|...) to P(T ≤ A, e=1 | X, W=w) × 1/p(e=1|...). Since the event {T ≤ A, e=1} ⊆ {T ≤ A}, basic probability gives P(T ≤ A | ...) ≥ P(T ≤ A, e=1 | ...), so the inequality direction would reverse (≥) if no additional assumptions are invoked. The paper references "Lemma A.1" in the (stripped) appendix for justification, but the main text provides no sketch, intuition, or condition for why this inequality holds as written. This is not a minor presentational gap — it is the linchpin of the method. Readers cannot verify the theoretical foundation from the material provided. The authors should either present Lemma A.1 in the main text or restructure the derivation to be self-contained and clearly correct.

- **The "exact" guarantee claim is overstated**: The abstract, introduction, and contributions repeatedly state that the method provides an "exact miscoverage guarantee" or "distribution-free exact guarantee." However, Theorem 4.1 gives coverage ≥ 1 − α − ½𝔼[|ω̂ − ω|], which is exact only when the weight function is known (ω̂ = ω). Otherwise, there is a coverage gap proportional to the L₁ error of the weight estimate. While the paper acknowledges this error term in the theorem, the high-level claims do not qualify it appropriately. Contrast this with standard split conformal prediction, which provides truly exact (distribution-free) marginal coverage without any estimation error term. The distinction between "exact" and "PAC-type" is real, but the paper's framing suggests their guarantee is on par with exact conformal prediction when in fact it inherits an approximation from weight estimation.

### Minor

- **Some real-data subgroups may undercover**: In Figure 4, the box plots for Induction Chemotherapy show several trials where coverage falls below the nominal 90% level (appearing around 0.87–0.88). The paper states the method "maintains the desired coverage rate" without providing confidence intervals or statistical tests for whether the observed under-coverage could be due to random variation across the 10 trials. A bootstrap or confidence interval for coverage on the real data would strengthen the empirical claims.

- **Insufficient detail about baseline methods**: The paper compares against "Uncal," "Naive," "Focus," and "Fused" baselines but does not specify whether the same quantile regression model was used for all methods or whether hyperparameters were tuned separately. Without this, the reader cannot assess whether the comparison is fair. Similarly, the "relative LPB" metric is not explicitly defined as relative to the oracle LPB.

- **The derivation uses inconsistent notation**: In Equation (1), the second line writes T(w) ≤ q̄_α^(w)(X) − c_(1-α)^(w)(τ), but the non-conformity score is V = q̂_τ^(w) − T̃, so V ≥ c implies T(w) ≤ q̂_τ^(w)(X) − c. The bar vs. hat and α vs. τ notation is not explained and creates confusion about which quantile estimator is being used.

### Trivial

None.

## Nice-to-Haves

- A sensitivity analysis varying the quality of the weight estimator γ̂(x) (e.g., misspecified models) would help quantify how the L₁ error term in Theorem 4.1 behaves in practice.
- The optimization over τ is described as per-test-point (τ*(x)), but it is unclear how computationally expensive this is and whether c_(1-α)^(w)(τ)(x) depends on x in a way that requires recomputation for each test point.
- Reporting coverage with confidence intervals on the real data would put the visual observation of under-coverage in some subgroups on firmer statistical ground.

## Removed Points

The following points raised by the reviewers are removed with justification:

1. **"The inequality could be reversed if p(e=1|X,W) is near 1" (Harsh Critic Critical Issue 1)**: The specific numerical counterexample about p(e=1) near 1 does not actually break the inequality — when p(e=1) ≈ 1, both sides are approximately equal. However, the broader concern about the unjustified derivation (step (ii)–(iii)) is valid and retained as a Major weakness (see above). This specific numerical argument is removed because it is not a correct demonstration of a flaw.

2. **"Missing related works"**: Removed per instruction — I cannot verify the existence of other works through external knowledge.

3. **"The paper does not discuss how γ̂ accuracy affects coverage"**: This is partially addressed because Theorem 4.1 explicitly quantifies the effect through ½𝔼[|ω̂−ω|], and the Discussion section mentions extreme censoring/ imbalance leading to inaccurate γ̂. A dedicated simulation would strengthen the paper but the absence is not a flaw.

4. **Strength Finder: "Exact marginal coverage guarantee for counterfactual LPB in general right-censored data"**: This strength conflicts with the verified weakness about overstated exactness claims. Removed per instruction.

5. **Harsh Critic's "PAC-type guarantee is also approximate so the novelty is less" framing**: The paper's contrast with PAC-type guarantees is valid — the bound in Theorem 4.1 is a deterministic inequality (conditionally on training data) rather than a high-probability statement, which is a meaningful distinction even though both are approximate in practice.

6. **"The outlier generation is unusual — the connection to real-world outliers is unclear"**: This is a subjective judgment about experiment design. The robustness demonstration is still informative. Removed.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Restructure the derivation in Equation (1) to be self-contained and clearly correct. Either present Lemma A.1 in the main text or provide an alternative path that avoids the problematic inequality. One natural approach: directly frame the problem as a covariate shift from ℙ_{X|W=w,e=1} to ℙ_X (which is what Theorem 4.1 already does) and skip the problematic chain of inequalities.

2. Qualify the "exact" claim throughout: state that the LPB achieves exact coverage when the weight function ω(x) is known, and otherwise the coverage gap is bounded by the L₁ error of the weight estimate. This honest framing would not weaken the contribution — it would strengthen credibility.

3. Add confidence intervals (e.g., bootstrap) to the real-data coverage results in Figure 4 to help assess whether observed deviations from 90% are within expected variability.

4. Clarify the notation in Equation (1) — use consistent q̂_τ (matching the non-conformity score definition) and explain the relationship between the quantile τ used in the score and the nominal level α.

## Calibration Anchors

The following anchor papers were retrieved across calibration rounds:

**Round 1 brackets**:
- Weak (<3.5): Budget-constrained Active Learning to De-censor Survival Data (2.00), Regression Conformal Prediction under Bias (2.50), Benchmarking Survival Models (2.33), Tube Loss (2.50) — All substantially weaker than current paper, which has formal theorems and real-data experiments.
- Middle (3.5–7.5): Conformal Prediction for Dose-Response Models with Continuous Treatments (5.80, Reject), Class-Conditional CP (4.60, Reject), Conformal Prediction via Truncating (4.75, Reject), Trust Scores (5.00, Reject) — Most comparable to the dose-response paper, which also applies weighted CP to a causal setting but lacks real data and formal theorems. The current paper is theoretically stronger but has a more serious derivation flaw.
- Strong (>7.5): Conformal Risk Control (7.00, Accept Spotlight), Identifying Representations for Intervention Extrapolation (8.00) — Both are methodologically cleaner and better-substantiated than the current paper.

**Round 2 narrowing**:
- Wasserstein-Regularized CP (6.67, Accept Poster): Solid theory and experiments but addresses a different problem (general distribution shift vs. survival). Current paper is notably weaker due to the derivation gap.
- Class-Conditional CP via Top-k (4.60, Reject): Similar level of mixed reviews. Current paper is somewhat stronger in scope and empirical validation but has a more central theoretical gap.

**Bracket**: Round 1 placed the paper between 3.5 and 7.5. Round 2 narrowed the plausible range: above the 2–3 band papers (which lack comparable theoretical contributions) and below the clean, well-justified ~6.5–7 papers. The closest comparator is the dose-response CP paper (5.80), but the current paper's unresolved derivation gap pushes it slightly lower.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>